Search Results - "Ooijevaar‐de Heer, Pleuni"

Refine Results
  1. 1
  2. 2

    Structural Determinants of Unique Properties of Human IgG4-Fc by Davies, Anna M., Rispens, Theo, Ooijevaar-de Heer, Pleuni, Gould, Hannah J., Jefferis, Roy, Aalberse, Rob C., Sutton, Brian J.

    Published in Journal of molecular biology (06-02-2014)
    “…Human IgG4, normally the least abundant of the four subclasses of IgG in serum, displays a number of unique biological properties. It can undergo heavy-chain…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Novel approach to monitor intravenous immunoglobulin pharmacokinetics in humans using polymorphic determinants in IgG1 constant domains by Tilburg, Sander J., Jacobs, Bart C., Ooijevaarde Heer, Pleuni, Fokkink, Willem‐Jan R., Huizinga, Ruth, Vidarsson, Gestur, Rispens, Theo

    Published in European journal of immunology (01-04-2022)
    “…Clinical efficacy of intravenous immunoglobulin treatment (IVIg) is related to its pharmacokinetic (PK) profile. Its usual evaluation, by measuring serum total…”
    Get full text
    Journal Article
  6. 6

    Human IgE does not bind to human FcRn by Brinkhaus, Maximilian, van der Kooi, Elvera J., Bentlage, Arthur E. H., Ooijevaar-de Heer, Pleuni, Derksen, Ninotska I. L., Rispens, Theo, Vidarsson, Gestur

    Published in Scientific reports (07-01-2022)
    “…The neonatal Fc receptor (FcRn) is known to mediate placental transfer of IgG from mother to unborn. IgE is widely known for triggering immune responses to…”
    Get full text
    Journal Article
  7. 7

    Rheumatoid factors do not preferentially bind to ACPA-IgG or IgG with altered galactosylation by Falkenburg, Willem J J, Kempers, Ayla C, Dekkers, Gillian, Ooijevaar-de Heer, Pleuni, Bentlage, Arthur E H, Vidarsson, Gestur, van Schaardenburg, Dirkjan, Toes, René E M, Scherer, Hans U, Rispens, Theo

    Published in Rheumatology (Oxford, England) (01-11-2017)
    “…Recent reports describe interactions between the two most prominent RA-related autoantibodies, RFs and ACPAs. The main aim of the present study was to…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    Rheumatoid factor autoantibody repertoire profiling reveals distinct binding epitopes in health and autoimmunity by Oskam, Nienke, Ooijevaar-De Heer, Pleuni, Kos, Dorien, Jeremiasse, Jorn, van Boheemen, Laurette, Verstappen, Gwenny M, Kroese, Frans G M, van Schaardenburg, Dirkjan, Wolbink, Gertjan, Rispens, Theo

    Published in Annals of the rheumatic diseases (01-07-2023)
    “…Rheumatoid factors (RF) are one of the hallmark autoantibodies characteristic of rheumatoid arthritis (RA), and are frequently observed in other diseases and…”
    Get more information
    Journal Article
  12. 12

    Mechanism of Immunoglobulin G4 Fab-arm Exchange by Rispens, Theo, Ooijevaar-de Heer, Pleuni, Bende, Onno, Aalberse, Rob C

    Published in Journal of the American Chemical Society (06-07-2011)
    “…Immunoglobulin G (IgG) antibodies are symmetrical molecules that may be regarded as covalent dimers of 2 half-molecules, each consisting of a light chain and a…”
    Get full text
    Journal Article
  13. 13

    Factors affecting IgG4-mediated complement activation by Oskam, Nienke, Damelang, Timon, Streutker, Marij, Ooijevaar-de Heer, Pleuni, Nouta, Jan, Koeleman, Carolien, Van Coillie, Julie, Wuhrer, Manfred, Vidarsson, Gestur, Rispens, Theo

    Published in Frontiers in immunology (26-01-2023)
    “…Of the four human immunoglobulin G (IgG) subclasses, IgG4 is considered the least inflammatory, in part because it poorly activates the complement system…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Dynamics of Inter-heavy Chain Interactions in Human Immunoglobulin G (IgG) Subclasses Studied by Kinetic Fab Arm Exchange by Rispens, Theo, Davies, Anna M., Ooijevaar-de Heer, Pleuni, Absalah, Samira, Bende, Onno, Sutton, Brian J., Vidarsson, Gestur, Aalberse, Rob C.

    Published in The Journal of biological chemistry (28-02-2014)
    “…Interdomain interactions between the CH3 domains of antibody heavy chains are the first step in antibody assembly and are of prime importance for maintaining…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Variable Domain N -Linked Glycans Acquired During Antigen-Specific Immune Responses Can Contribute to Immunoglobulin G Antibody Stability by van de Bovenkamp, Fleur S, Derksen, Ninotska I L, van Breemen, Mariëlle J, de Taeye, Steven W, Ooijevaar-de Heer, Pleuni, Sanders, Rogier W, Rispens, Theo

    Published in Frontiers in immunology (12-04-2018)
    “…Immunoglobulin G (IgG) can contain -linked glycans in the variable domains, the so-called Fab glycans, in addition to the Fc glycans in the C 2 domains. These…”
    Get full text
    Journal Article
  18. 18

    Next-generation rheumatoid factor assay provides improved predictive power for the development of arthritis in patients at risk by Oskam, Nienke, Ooijevaar-de Heer, Pleuni, Kos, Dorien, van Boheemen, Laurette, van Schaardenburg, Dirkjan, Wolbink, Gertjan, Rispens, Theo

    Published in Rheumatic & musculoskeletal diseases open (20-08-2024)
    “…ObjectiveRheumatoid arthritis (RA) is characterised by the presence of autoantibodies, among which those targeting the constant region of immunoglobulin G…”
    Get full text
    Journal Article
  19. 19

    Infusion reactions during infliximab treatment are not associated with IgE anti-infliximab antibodies by van Schie, Karin A, Ooijevaar-De Heer, Pleuni, Kruithof, Simone, Plasencia, Chamaida, Jurado, Teresa, Pascual Salcedo, Dora, Brandse, Johannan F, d'Haens, Geert Ram, Wolbink, Gerrit Jan, Rispens, Theo

    Published in Annals of the rheumatic diseases (01-07-2017)
    “…Controversy exists on the role of IgE antidrug antibodies (IgE-ADA) in infusion reactions (IR) on infliximab treatment, partly due to the lack of a positive…”
    Get more information
    Journal Article
  20. 20